Aurora Cannabis ACB shares are trading higher after the company provided a progress update on its previously announced "Business Transformation Plan."
The company said it will exit 2020 at a selling, general & administrative run rate of roughly $42 million and it remains on track for positive adjusted EBITDA in the first quarter of 2021.
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis. Although the company primarily operates in Canada, Aurora has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 25 countries.
Aurora Cannabis was trading 5.2% higher to $14.42 at the time of publication on Tuesday. The stock has a 52-week high of $95.76 and a 52-week low of $5.30.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.